Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13Neoplasms 12Colorectal Neoplasms 12Pain 11Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 7Agnosia 6Colonic Neoplasms 5Cancer Pain 5Neuralgia 4Keratosis, Actinic 4Head and Neck Neoplasms 4Liver Neoplasms 3Leiomyoma 3Chronic Pain 3Thyroid Neoplasms 2Stomatitis 2Stomach Neoplasms 2Recurrence 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Mucositis 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Mindfulness-Based Stress Reduction 2Yoga 1Lidocaine 1Folfox protocol 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuropathy, Painful × Lidocaine × Clear all
NCT03254394 2022-03-09

Lidocaine for Oxaliplatin-induced Neuropathy

Washington University School of Medicine

Phase 1/2 Completed
26 enrolled 10 charts
Gastrointestinal

Neuropathy, Painful, Cold Hypersensitivity, Neuralgia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡